SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 3.54 |
Enterprise Value ($M) | 11.52 |
Book Value ($M) | 3.96 |
Book Value / Share | 2.69 |
Price / Book | 0.90 |
NCAV ($M) | 3.58 |
NCAV / Share | 2.43 |
Price / NCAV | 0.99 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.93 |
Return on Assets (ROA) | -0.95 |
Return on Equity (ROE) | -1.12 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.98 |
Current Ratio | 3.25 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 5.39 |
Assets | 5.76 |
Liabilities | 1.80 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.68 |
Operating Income | -9.71 |
Net Income | -7.95 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -5.65 |
Cash from Investing | -1.89 |
Cash from Financing | 7.05 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Armistice Capital, Llc | 9.99 | 142.97 | |
13G | Intracoastal Capital, Llc | 4.99 | ||
13G/A | Knight Therapeutics Inc | 9.10 | ||
13G/A | Knight Therapeutics (Barbados) Inc. | 9.97 | 4.11 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
4,484 | 22,272 | 20.13 | |
5,892 | 18,771 | 31.39 | |
7,709 | 36,557 | 21.09 | |
25,784 | 100,369 | 25.69 | |
(click for more detail) |
Similar Companies | |
---|---|
SONN – Sonnet BioTherapeutics Holdings, Inc. | SRZN – Surrozen, Inc. |
SXTC – China SXT Pharmaceuticals, Inc. | SYBX – Synlogic, Inc. |
TCRT – Alaunos Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io